维普中文期刊产品整合服务
299篇 您的检索式:作者名="Laarman"
    题名 作者 年代 出处 被引量
1断奶过渡期荷斯坦犊牛开食料中淀粉含量对犊牛生长性能及瘤胃pH的影响显示文摘本研究旨在评价荷斯坦犊牛断奶过渡期,其开食料中以高纤维的副产品替代玉米对犊牛生长和瘤胃pH的影响。荷斯坦公犊牛强化饲喂,代乳料包含26%粗蛋白质和18%脂肪。犊牛饲喂开口颗粒料(以干物质为基础),其中含有18.8%玉米(CRN组),或10.2%甜菜浆代替玉米(BP组),或18.6%DDGS取代玉米和高蛋白质饲料(DDGS组);不同处理组仅在颗粒部分有所区分。CRN、BP和DDGS 3个组的淀粉含量分别为35.3%、33.4%和31.4%。犊牛连续饲喂3d,消耗2.5kg开口料后,将瘤胃pH测定仪经口腔插入,连续4d测定瘤胃pH。屠宰后,取瘤胃食糜测定可挥发性脂肪酸。结果表明,各处理组之间日增重、生长速度、臀高、肩隆高及心脏周长均没有显著差异。在断奶过渡期,DDGS组开口料的摄入量高于CRN组(87.7vs77.5g/d),BP组低于CRN组(68.1vs77.5g/d)。DDGS组瘤胃内pH低于5.8(470vs295 min×pH/d)和pH低于5.2(72.7vs16.4min×pH/d)的区域大于CRN组。与CRN组相比,瘤胃pH不受BP影响,但BP组犊牛的饮水量大于CRN组(6.6vs5.8L/d)。各处理组间挥发性脂肪酸含量无差异,但BP组丁酸含量低于CRN组(15.0%vs16.6%)。干草摄入量与瘤胃pH呈正相关(r=0.48)。在犊牛断奶期间,降低日粮淀粉含量不能减轻瘤胃酸中毒症,低瘤胃pH对生产性能没有影响。Laarman 孙鹏 2012中国畜牧兽医2012,39,10:2
2A randomized comparison of percutaneous transluminal coronary angioptasty by the radial, brachial and femoral approaches:the access study显示文摘KIEMENEIJ F LAARMAN G H ODEKERKEN D 1997J Am Coll Cardiol1997,29,6:2
3A Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty by the Radial, Brachial and Femoral Approaches: The Access Study显示文摘Ferdinand Kiemeneij Gert Jan Laarman Diego Odekerken Ton Slagboom Ron van der Wieken 1997Journal of the American College of Cardiology1997,,6:2
4A randomized compare-8011 of precutaneous transluminal coronary angioplasty by the radial,brachial and femoral approaches:the access study显示文摘Kiemeneij F Laarman吲 Odekerken D 2007JAm CoilCardiol2007,29,:1
5Incidence and outcome of radial artery occlusion following transradial artery coronary angplasty显示文摘Stella PR Kiemeneiji F Laarman GJ 1997Cathet Cardiovasc Diagn1997,40,2:1
6Pricing policy in nature-based tourism 显示文摘Laarman J G Gregersen H M 1996Tourism Management1996,17,4:1
7Pacli- taxel-eluting versus uncoated stents in primary percutaneous coronary intervention 显示文摘LAARMAN G J suTroRP M J DIRKSEN M T 2006N Engl J Med2006,355,11:1
8Percutaneous radial artery approach for coronary stent implantation显示文摘Kiemeneij F Laarman GJ 1993Cathet Cardiouasc Diagn1993,30,:1
9Percutaneous transradial artery approach for coronary Palmaz-Schatz stent implantation 显示文摘Kiemeneij F Laarman GJ 1994Am Heart J1994,128,:1
10Percutaneous trans-radial artery Palmaz-Schatz coronary stendt implantion:results of single-center feasibility study显示文摘Kiemeneij F Laarman GJ 1995Am Heart J1995,130,:1
11The value of N- terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST- elevation acute coronary syndromes显示文摘Riezebos RK Laarman GJ Tijssen JG 2011Clin Chem Lab Med2011,49,8:1
12Outpatient coronary stent implantation显示文摘Kiemeneij F Laarman GJ Slagboom T 1997J Am Coll Cardiol1997,29,2:1
13Randomized,double-blind,multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions:clinical and angiographic results of the ENDEAVOR Ⅱ trial显示文摘Fajadet J Wijns W Laarman GJ 2006Circulation2006,114,8:1
14Transradial approach for percutaneous transluminal angioplasty and stenting显示文摘Slagboom T Kiemeneij F Laarman G J 2005Catheter Cardiovasc Interv2005,64,4:1
15Transradial artery coronary angioplasty显示文摘Kiemeneij F Laarman G J de Melker E 1995Am Heart J1995,129,1:1
16A random-ized comparison of percutaneous transluminal coronary an-gioplasty by the radial brachial and femoral approaches:the access study显示文摘Kiemeneij F Laarman GH Odekerken D 1997J Am Coll Cardiol1997,29,5:1
17A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches, the access study显示文摘Kiemeneij F Laarman GH Odekerken D 1997J Am Coll Cardiol1997,29,:1
18Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention 显示文摘Laarman GJ Suttorp M J Dirksen MT 2006N Engl J Med2006,355,:1
19Overview of the tran-sradial approach in percutaneous coronary intervention显示文摘Amoroso G Laarman GJ Kiemeneij F 0,,:1
20A randomized comparison of perecutaneous transluminal coronary angioplasty by rqadial,brachial and femoral approaches:the access study显示文摘Kiemeneij F Laarman GJ Odekerken D 1997J Am Coll Cardiol1997,29,6:1
返回顶部 每页显示:
共15页 首页 上一页 第1页 下一页 末页 /15 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费